Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02909062 · ClinicalTrials.gov registry record
Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy.
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 54
- Enrollment target
NCT02909062: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02909062 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02909062 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
Electronic activity monitoring (EAM) devices are wearable electronic devices that monitor functional activity and provide personal feedback on activity progression. This study aims to determine if EAM can provide an objective, assessment of patient functional activity. The study will also examine the change in functional activity experienced by patients during the first cycle of chemotherapy. Another objective of the study will be to see if baseline functional activity and the change in functional activity that occurs during the first cycle of chemotherapy can be used to predict patient tolerability of subsequent cycles of chemotherapy.
Primary Outcome
change in physical activity between pre-chemotherapy and on-chemotherapy by counting the steps
Interventions
- DEVICE Electronic Activity Monitoring (EAM)
- BEHAVIORAL Daily Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2016-05 |
| Est. Completion | 2020-08-21 |
What the finished NCT02909062 record still lists
NCT02909062 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Electronic Activity Monitoring (EAM) is the first listed.
NCT02909062 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02909062 about?
NCT02909062 is a clinical study titled "Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy.". Electronic activity monitoring (EAM) devices are wearable electronic devices that monitor functional activity and provide personal feedback on activity progression. This study aims to determine if EAM can provide an objective, assessment of patient functional activity. The study will also examine th...
What is the current status of trial NCT02909062?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2016-05. Estimated completion is 2020-08-21.
What interventions are being tested in trial NCT02909062?
The interventions under investigation include: Electronic Activity Monitoring (EAM) (DEVICE), Daily Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02909062?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia